Mineralocorticoid receptors in brain, in health and disease: Possibilities for new pharmacotherapy

European Journal of Pharmacology

Volumn 583, Issue 2-3, 2008, Pages 372-378

  Kellner, Michael ^a   Wiedemann, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Anxiety; Depression; Mineralocorticoid receptors; Psychopharmacology; Stress

Indexed keywords

MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; PSYCHOTROPIC AGENT;

AFFECT; CORTICOSTEROID METABOLISM; DRUG RESEARCH; HORMONAL REGULATION; HUMAN; MENTAL DISEASE; MOOD; NEUROENDOCRINOLOGY; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SLEEP; STRESS;

ANIMALS; BRAIN; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; HUMANS; MENTAL DISORDERS; PROTEIN BINDING; PSYCHOTROPIC DRUGS; RECEPTORS, MINERALOCORTICOID; STRESS;

EID: 40849123876     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.072     Document Type: Review

References (73)

1. Armanini D., Spinella P., Simoncini M., Basso A., Zovato S., Pozzan G.B., De Palo C.B., Bucciante G., and Karbowiak I. Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's disease. J. Endocrinol. 158 (1998) 435-439
2. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., and Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275
3. Arvat E., Maccagno B., Giordano R., Pellegrino M., Broglio F., Gianotti L., Maccario M., Camanni F., and Ghigo E. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. J. Clin. Endocrinol. Metab. 86 (2001) 3176-3181
4. Barden N. Regulation of corticosteroid receptor gene expression in depression and antidepressant action. J. Psychiatry Neurosci., 24 (1999) 25-39
5. Berger S., Wolfer D.P., Selbach O., Alter H., Erdmann G., Reichardt H.M., Chepkova A.N., Welzl H., Haas H.L., Lipp H.P., and Schütz G. Loss of the limbic mineralocorticoid receptor impairs behavioural plasticity. Proc. Natl. Acad. Sci. USA 103 (2006) 195-200
6. Blockmans D., Perssons P., Van Houdenhove B., Lejeune M., and Bobaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am. J. Med. 114 (2003) 736-741
7. Born J., DeKloet E.R., Wenz H., Kern W., and Fehm H.L. Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am. J. Physiol. 260 (1991) E183-E188
8. Born J., Steinbach D., Dodt C., and Fehm H.-L. Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep. J. Clin. Endocrinol. Metab. 82 (1997) 1106-1110
9. Bradbury M.J., Akana S.F., and Dallmann M.F. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hyothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology 134 (1994) 1286-1296
10. Buckley T., Mullen B., Flores B., and Schatzberg A. Effects of the mineralocorticoid receptor agonist, fludrocortisone, on nocturnal cortisol in healthy controls - preliminary results. Int. J. Neuropsychopharmacol. 9 (2006) S187
11. Buckley T.M., and Schatzberg A.F. Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation. Am. J. Geriatr. Psychiatry 13 (2005) 344-352
12. Calvo N., and Volosin M. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint. Neuroendocrinology 73 (2001) 261-271
13. Cole M.A., Kalman B.A., Pace T.W.W., Topczewski F., Lowrey M.J., and Spencer R.L. Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation. J. Neuroendocrinol. 12 (2000) 1034-1042
14. DeKloet E.R., Wallach G., and McEwen B. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 96 (1975) 598-609
15. DeRijk R.H., Wust S., Meijer O.C., Zennaro M.C., Federenko I.S., Hellhammer D.H., Giacchetti G., Vreugdenhil E., Zitman F.G., and de Kloet E.R. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J. Clin. Endocrinol. Metab. 91 (2006) 5083-5098
16. Deuschle M., Weber B., Colla M., Müller M., Kniest A., and Heuser I. Mineralocorticoid receptor also modulated basal activity of hypothalamus-pituitary-adrenocortical system in humans. Neuroendocrinology 68 (1998) 355-360
17. Dodt C., Kern W., Fehm H.L., and Born J. Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 58 (1993) 570-574
18. Douma B.R.K., Korte S.M., Buwalda B., LaFleur S.E., Bohus B., and Luiten P.G.M. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded special learning. Psychoneuroendocrinology 23 (1998) 33-44
19. Gass P., Reichardt H.M., Strekalova H., Henn F., and Tronche F. Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for anxiety and depression?. Physiol. Behav. 73 (2001) 811-825
20. Gesing A., Bilang-Bleuel A., Droste S.K., Linthorst A.C., Holsboer F., and Reul J.M. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J. Neurosci. 21 (2001) 4822-4829
21. Grottoli S., Giordano R., Maccagno B., Pellegrino M., Ghigo E., and Arvat E. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine in humans. J. Clin. Endocrinol. Metab. 87 (2002) 4616-4620
22. Hendler H.N. Spironolactone prophylaxis in manic-depressive disease. J. Nerv. Ment. Dis. 166 (1978) 517-520
23. Heuser I., Deutschle M., Weber B., Kniest A., Ziegerl C., Weber B., and Colla M. The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age. Neurobiol. Aging 21 (2000) 585-589
24. Heuser I., Deuschle M., Weber B., Stalla G.K., and Holsboer F. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 25 (2000) 513-518
25. Jahn H., Schick M., Kiefer F., Kellner M., Yassouridis A., and Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch. Gen. Psychiatry 61 (2004) 1235-1344
26. Kalman B.A., and Spencer R.L. Rapid corticosteroid-dependent regulation of mineralocorticoid receptor protein expression in rat brain. Endocrinology 143 (2002) 4184-4195
27. Kellner M., Baker D.G., Yassouridis A., Bettinger S., Otte C., Naber D., and Wiedemann K. Mineralocorticoid receptor function in patients with posttraumatic stress disorder. Am. J. Psychiatry 159 (2002) 1938-1940
28. Kellner M., and Wiedemann K. Antimineralocorticoid challenge. In: Fink G. (Ed). Encyclopedia of Stress. second edition (2007), Academic Press Inc., Burlington, MA
29. Kuningas M., de Rijk R.H., Westendorp R.G., Jolles J., Eline Slagboom P., and van Heemst D. Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors. Neuropsychopharmacology 32 (2007) 1295-1301
30. Lai M., Horsburgh K., Bae S.E., Carter R.N., Stenvers D.J., Fowler J.H., Yau J.L., Gomez-Sanchez C.E., Holmes M.C., Kenyon C.J., Seckl J.R., and Macleod M.R. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischemia. Eur. J. Neurosci. 25 (2007) 1832-1842
31. Lau J.L.W., Noble J., and Seckl J.R. Continuous blockade of brain mineralocorticoid receptors impairs spatial learning in rats. Neurosci. Lett. 277 (1999) 45-48
32. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Ann. N. Y. Acad. Sci. 836 (1998) 106-134
33. Ménard J. The 45-year story of the development of an anti-aldosterone more specific than spironolactone. Mol. Cell. Endocrinol. 217 (2004) 45-52
34. Mason B.L., and Pariante C.M. The effects of antidepressants on the hypothalamic-pituitary-adrenal axis. Drug News Perspect. 19 (2006) 603-608
35. McEwen B.S., Weiss J.M., and Schwartz L.S. Selective retention of corticosterone by limbic structures in rat brain. Nature 220 (1968) 911-912
36. Meyer U., Kruhoffer M., Flgge G., and Fuchs E. Cloning of glucocorticoid receptor and mineralocorticoid receptor cDNA and gene expression in the central nervous system of the tree shrew (Tupaia belangeri). Mol. Brain Res. 55 (1998) 243-253
37. Michelson D., Chrousos G.P., and Gold P.W. Type I glucocorticoid receptor blockade does not affect baseline or ovine corticotrophin-releasing-hormone-stimulated adrenocorticotropic hormone and cortisol secretion. Neuroimmunomodulation 1 (1994) 274-277
38. O'Brien M.P.S., Craven D., Selby C., and Symonds E.M. Treatment of premenstrual syndrome by spironolactone. Br. J. Obstet. Gynaecol. 86 (1979) 142-147
39. Oitzl M.S., Fluttert M., and DeKloet E.R. Acute blockade of hippocampal glucocorticoid receptors facilitates spatial learning in rats. Brain Res. 797 (1998) 159-162
40. Otte C., Jahn H., Yassouridis A., Arlt J., Stober N., Maass P., Wiedemann K., and Kellner M. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sci. 73 (2003) 1835-1845
41. Otte C., Yassouridis A., Jahn H., Maass P., Stober N., Wiedemann K., and Kellner M. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. J. Gerontol. Biol. Sci. 58A (2003) 900-905
42. Otte C., Muhtz C., Daneshkhah S., Yassouridis A., Kiefer F., Wiedemann K., and Kellner M. Mineralocorticoid receptor function in PTSD after pre-treatment with metyrapone. Biol. Psychiatry 60 (2006) 784-787
43. Otte C., Moritz S., Yassouridis A., Koop M., Madrischewski A.M., Wiedemann K., and Kellner M. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 32 (2007) 232-238
44. Patel P.D., Lopez J.F., Lyons D.M., Burke S., Wallace M., and Schatzberg A.F. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J. Psychiat. Res. 34 (2000) 383-392
45. Pace T.W.W., and Spencer R.L. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1082-E1088
46. Peterson P.K., Pheley A., Schroeppel J., Schenck C., Marshall P., Kind A., Haugland J.M., Lambrecht L.J., Swan S., and Goldsmith S. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch. Int. Med. 158 (1998) 908-914
47. Pryce C.R., Feldon J., Fuchs E., Knuesel I., Oertle T., Sengstag C., Spengler M., Weber E., Weston A., and Jongen-Relo A. Postnatal ontogeny of hippocampal expression of the mineralocorticoid and glucocorticoid receptors in the common marmoset monkey. Eur. J. Neurosci. 21 (2005) 1521-1535
48. Raedler T.J., Jahn H., Goedeken B., Gescher D.M., Kellner M., and Wiedemann K. Megestrol attenuates the hormonal response to CCK-4 induced panic attacks. Depress. Anxiety 23 (2006) 139-144
49. Ratka A., Sutanto W., Bloemers M., and de Kloet E.R. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50 (1989) 117-123
50. Reul J.M.H.M., and DeKloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985) 2505-2512
51. Reul J.M.H.M., Stec I., Söder M., and Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133 (1993) 312-320
52. Reul J.M.H.M., Labeur M.S., Grigoriadis D.E., DeSouza E.B., and Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60 (1994) 509-519
53. Reul J.M.H.M., Probst J.C., Skutella T., Hirschmann M., Stec I.S.M., Montkowski A., Landgraf R., and Holsboer F. Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides. Neuroendocrinology 65 (1997) 189-199
54. Reul J.M.H.M., Gesing A., Droste S., Stec I.S.M., Weber A., Bachmann C., Bilang-Bleuel A., Holsboer F., and Linthorst A.C.E. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur. J. Pharmacol. 405 (2000) 235-249
55. Rozeboom A.M., Akil H., and Seaholtz A.F. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc. Natl. Acad. Sci. USA 104 (2007) 4688-4692
56. Sanchez M.M., Young L.J., Plotsky P.M., and Insel T.R. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J. Neurosci. 20 (2000) 4657-4668
57. Seckl J.R. 11ß-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?. Front. Neuroendocrinology 18 (1997) 49-99
58. Semont A., Fache M.-P., Ouafik L., Hery M., Faudon M., and Hery F. Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures. Neuroendocrinology 69 (1999) 121-128
59. Smythe J.W., Murphy D., Timothy C., and Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety behavior in rats. Pharmacol. Biochem. Behav. 56 (2000) 507-513
60. Spencer R.L., Kim P.J., Kalman B.A., and Cole M.A. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 139 (1998) 2718-2726
61. Steiger A., Rupprecht R., Spengler D., Guldner J., Hemmeter U., Rothe B., Damm K., and Holsboer F. Functional properties of deoxycorticosterone and spironolactone: molecular characterization and effects on sleep-endocrine activity. J. Psychiatr. Res. 27 (1993) 275-284
62. Sutanto W., and DeKloet E.R. Species-specificity of corticosteroid receptors in hamster and rat brains. Endocrinology 121 (1987) 1405-1411
63. Tytherleigh M.Y., Vedhara K., and Lightman S.F. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison's disease. Psychoneuroendocrinology 29 (2004) 712-723
64. Van Haarst A.D., Oitzl M., and de Kloet E.R. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem. Res. 22 (1997) 1323-1328
65. Wang M., Hammarsback S., Lindhe B.A., and Backstrom T. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet. Gynecol. Scand. 74 (1995) 803-808
66. Watzka M., Beyenburg S., Blümcke I., Elger C.E., Bidlingmaier F., and Stoffel-Wagner B. Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neurosci. Lett. 290 (2000) 121-124
67. Weinberger M.H. Eplenerone: a new selective aldosterone receptor antagonist. Drugs Today 40 (2004) 481-485
68. Wellhoener P., Born J., Fehm L.H., and Dodt C. Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J. Clin. Endocrinol. Metab. 89 (2004) 5048-5052
69. Wernze H. Surprising effect of spironolactone on eating behaviour and mood in bulimia nervosa. Psychopharmakotherapie 7 (2000) 33-39
70. Wiedemann K., Lauer C., Pollmächer T., and Holsboer F. Sleep endocrine effects of antigluco- and antimineralocorticoids in healthy males. Am. J. Physiol. 267 (1994) E109-E114
71. Yau J.L.W., Noble J., Kenyon C.J., Hibberd C., Kotulevtsev Y., Mullins J.J., and Seckl J.R. Lack of glucocorticoid reactivation in 11ß-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age related learning impairments. Proc. Nat. Acad. Sci. 98 (2001) 4716-4721
72. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., and Akil H. The role of mineralocorticoid receptors in HPA axis regulation in humans. J. Clin. Endocrinol. Metab. 83 (1998) 3339-3345
73. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., and Akil H. Mineralocorticoid receptor function in major depression. Arch. Gen. Psychiatry 60 (2003) 24-28